Impact of Pharmacist Interventions on Direct-Acting Antivirals Sustained Virologic Responde and Drug-Drug Interactions

Impact of Pharmacist Interventions on Direct-Acting Antivirals Sustained Virologic Responde and Drug-Drug Interactions

Marcel Nogueira

Contact

Impact of Pharmacist Interventions on Direct-Acting Antivirals Sustained Virologic Responde and Drug-Drug Interactions

Article Fingerprint

ReserarchID

PDDTMS4ZRY

Impact of Pharmacist Interventions on Direct-Acting Antivirals Sustained Virologic Responde and Drug-Drug Interactions Banner

AI TAKEAWAY

Connecting with the Eternal Ground

References

23 Cites in Article

Reference Format

Jeffrey Stanaway,Abraham Flaxman,Mohsen Naghavi,Christina Fitzmaurice,Theo Vos,Ibrahim Abubakar,Laith Abu-Raddad,Reza Assadi,Neeraj Bhala,Benjamin Cowie,Mohammad Forouzanfour,Justina Groeger,Khayriyyah Hanafiah,Kathryn Jacobsen,Spencer James,Jennifer Maclachlan,Reza Malekzadeh,Natasha Martin,Ali Mokdad,Ali Mokdad,Christopher Murray,Dietrich Plass,Saleem Rana,David Rein,Jan Richardus,Juan Sanabria,Mete Saylan,Saeid Shahraz,Samuel So,Vasiliy Vlassov,Elisabete Weiderpass,Steven Wiersma,Mustafa Younis,Chuanhua Yu,Maysaa El Sayed Zaki,Graham Cooke (2016). The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.
E Gane,D Kershenobich,C Seguin-Devaux,Kristian Aho,I,Dalgard (2015). Strategies to manage hepatitis virus (HCV) infection disease burdenvolume 2.
J Chhatwal,X Wang,T Ayer,M Kabiri,R Chung,C Hur (2016). Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals.
(2017). WHO Expert Committee on Drug Dependence: Twenty-eighth report..
Who (2016). Combating Hepatitis B and C to Reach Eliminationby.
B Maasoumy,K Port,Calle Serrano,B Markova,A Sollik,L Manns,M (2013). The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.
Brasil Protocolo Clínico e Diretrizes Terapêuticas para o tratamento da hepatite viral crônica C e co-infecções.
Liverpool Uo (2017). HEP Drug Interactions.
Jean-Michel Pawlotsky,Francesco Negro,Alessio Aghemo,Marina Berenguer,Olav Dalgard,Geoffrey Dusheiko,Fiona Marra,Massimo Puoti,Heiner Wedemeyer (2018). EASL Recommendations on Treatment of Hepatitis C 2018.
Clara De Kanter,Joost Drenth,Joop Arends,Henk Reesink,Marc Van Der Valk,Robert De Knegt,David Burger (2014). Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations.
Tushar Garimella,Reena Wang,Wen-Lin Luo,Carey Hwang,Diane Sherman,Hamza Kandoussi,Thomas Marbury,Harry Alcorn,Richard Bertz,Marc Bifano (2015). Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects with Renal Function Impairment.
T Saussele,O Burk,J Blievernicht,K Klein,A Nussler,N Nussler (2007). Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole.
Timothy Gauthier,Eva Moreira,Chantal Chan,Alexandria Cabrera,Maribel Toro,Mara Carrasquillo,Mark Corentin,Elizabeth Sherman (2016). Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
R Abreu,Silva Da,C Ferreira,A Ferreira,E Remor,P Nasser,F Carrilho (2016). Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B.
J Langness,M Nguyen,A Wieland,G Everson,J Kiser (2017). Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions.
M Kooy,Ecg Van Geffen,E Heerdink,L Van Dijk,M Bouvy (2014). Effects of a Telephone Counselling Intervention by Pharmacist (TelCIP) on medication adherence, patient beliefs and satisfaction with information for patients starting treatment: study protocol for a cluster randomized controlled trial.
A Ottman,M Townsend,M Hashem,V Dimondi,R Britt (2018). Incidence of Drug Interactions Identified by Clinical Pharmacists in Veterans Initiating Treatment for Chronic Hepatitis C Infection.
Franz Faul,Edgar Erdfelder,Axel Buchner,Albert-Georg Lang (2009). Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses.
H Cheinquer,H Sette,Jr Wolff,F De Araujo,A Coelho-Borges,S Soares,Srp (2017). Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil.
V Ferreira,Hhl Borba,A Wiens,Mla Pedroso,Vfc Radunz,Cap Ivantes (2018). Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases.
M Sulkowski,D Gardiner,M Rodriguez-Torres,K Reddy,T Hassanein,I Jacobson (2014). Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.
Elise Smolders,Floor Berden,Clara De Kanter,Wietske Kievit,Joost Drenth,David Burger (2017). The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug‐drug interactions.
Paulo Arrais,Maria Fernandes,Tatiane Pizzol,Luiz Ramos,Sotero Mengue,Vera Luiza,Noemia Tavares,Mareni Farias,Maria Oliveira,Andréa Bertoldi (2016). Prevalence of self-medication in Brazil and associated factors.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Marcel Nogueira. 2020. \u201cImpact of Pharmacist Interventions on Direct-Acting Antivirals Sustained Virologic Responde and Drug-Drug Interactions\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 20 (GJMR Volume 20 Issue B3).

More Citation Formats

Select Citation Style:

Download Citation

GJMR Volume 20 Issue B3

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-B Classification NLMC Code: QW 4

Submission ReceivedDecember 8, 2019
Peer Review Double Blind
Handling Editor
Accepted December 31, 2019
Published January 15, 2020

Version of record

v1.2

Issue date

April 7, 2020

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Views: 2554

Total Downloads: 1198

2026 Trends

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]